Brief: Natco Pharma- Claims Against Co In Louisiana Antitrust Litigation Dismissed
21/12/2023 06:25
Dec 21 (Reuters) - Natco Pharma Ltd NATP.NS :
* NATCO PHARMA LTD- CO NAMED AS A DEFENDANT IN AN ANTITRUST
LAWSUIT IN US BY LOUISIANA HEALTH SERVICE & INDEMNITY COMPANY
* NATCO PHARMA LTD- ALL CLAIMS AGAINST COMPANY IN LITIGATION
HAVE
NOW BEEN DISMISSED
Source text for Eikon: ID:nBSEc7VbJ0
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees